🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Biological therapies such as flt3L and CD40-ligand use different...
Status
Completed
Location
Surgery Branch
Start Date
2001-03
Trial ID
NCT00020540
Treatments Being Tested
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-11
Trial ID
NCT00006225
This phase II trial studies the effect of a vaccine called CDX-1401 given w...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2014-04-09
Trial ID
NCT02129075
Treatments Being Tested
RATIONALE: Flt3L may stimulate a person's immune system and help kill tumor...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
1998-06
Trial ID
NCT00003431
Treatments Being Tested
Despite advances in their classification and treatment, acute leukemia rema...
Status
Completed
Location
Nantes University Hospital
Start Date
2016-05-27
Trial ID
NCT02693899
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of AdV-HSV1...
Status
Recruiting
Location
University of Michigan Comprehensive Cancer Center
Start Date
2026-05-22
Trial ID
NCT06914479
This is a pilot clinical trial to assess the feasibility and efficacy of ex...
Status
Terminated
Location
Singapore General Hospital
Start Date
2012-03
Trial ID
NCT01624701
Treatments Being Tested
Our recent trials combining local radiotherapy with intratumoral administra...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2014-01-03
Trial ID
NCT01976585
Treatments Being Tested
This is an open-label, multicenter, prospective pilot study of CDX-301 with...
Status
Terminated
Location
UCLA Medical Center
Start Date
2014-07
Trial ID
NCT02200380
Treatments Being Tested
CDX-301 is a protein that stimulates the growth of bone marrow stem cells a...
Status
Completed
Location
Rockefeller University
Start Date
2011-10
Trial ID
NCT01465139
Treatments Being Tested